About IntraLase
IntraLase is a Healthcare company based in Irvine (United States) founded in 1997, and was acquired by Abbott in March 2007. Femtosecond laser technology is developed for eye surgery procedures. IntraLase has raised $29.5 million across 2 funding rounds from investors including Abbott, Brentwood Associates and InterWest. Its chief executive, as recorded, is Robert J Palmisano. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its competitors include Clerio Vision and Lenticular Research Group; 2 of its 2 listed competitors have raised funding.
Company details
IntraLase was founded in 1997 in Irvine, United States, focusing on femtosecond laser technology within the medical sector, particularly for ophthalmology. The technology, now trademarked as IntraLase and owned by AMO, enables IntraLASIK procedures. The company went public in 2004 and was acquired by Advanced Medical Optics in 2007 for 808 million. Advanced Medical Optics was subsequently acquired by Abbott Laboratories in 2009.
- Headquarters Irvine, United States
- Stage Acquired
- SectorsHealthcare
- Website intralase.com
- Acquired by Abbott (Mar 2007)
Funding Insights of IntraLase
IntraLase has successfully raised a total of $29.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $22 million completed in October 2000. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $29.5M
- Total Rounds 2
- Last Round Series B — $22M
- First Round $7.5M
(Sep 1999)
- Investors Count 2
All 2 funding rounds of IntraLase with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2000 | $22M | Series B | – | – | |
| Sep 1999 | $7.5M | Series B | – | – |
3 investors in total: 3 institutional.
Investors in IntraLase
IntraLase has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Abbott, Brentwood Associates and InterWest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Brentwood Associates is engaged in growth-oriented private equity investments. | brentwood.com | Los Angeles, United States | ||
Early-stage investing in IT and healthcare ventures. | interwest.com | |||
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | abbott.com | Libertyville, United States |
Investor details for IntraLase
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of IntraLase
1 people are tracked at IntraLase (1 in leadership).
| Name | Role | Group |
|---|---|---|
Robert J Palmisano | CEO & President | Leadership |
Complete people profiles for IntraLase
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of IntraLase
5 dated milestones of IntraLase across 10 years, from founding to its latest funding, stage changes and deals.
- Founded IntraLase is founded.
- Funding First funding round of $7.5M.
- Funding Latest funding round, Series B, of $22.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Abbott.
Competitors of IntraLase
IntraLase has 2 listed competitors in our database, 2 of them funded. They include Clerio Vision and Lenticular Research Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cleriovision.com | 2014 | Rochester, United States | $28.95M | 90 | Laser induced change in refractive index | |
| lenticularresearchgroup.com | 2007 | Naperville, United States | $330,000 | Developer of laser device for treating the cause of presbyopia |
Detailed competitors of IntraLase
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IntraLase
Websites that share an audience with IntraLase (intralase.com).
Websites whose visitors overlap most with IntraLase. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
seewithlasik.com | seewithlasik.com | 100% | – | ||
asklasikdocs.com | asklasikdocs.com | 100% | – | ||
lasiksurgerynews.com | lasiksurgerynews.com | 100% | #7,918,379 | – | |
| mayoclinic.org | 100% | 62.3M | #1,090 | View details | |
smileyes.de | smileyes.de | 95% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for IntraLase
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as IntraLase (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IntraLase
IntraLase was founded in 1997 and raised its 1st funding round 2 years after it was founded.
IntraLase is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Robert J Palmisano is the CEO of IntraLase, as recorded in our data.
IntraLase is a funded company, having raised a total of $29.5M across 2 funding rounds to date. The company's 1st funding round was a Series B of $7.5M, raised on Sep 1999.
IntraLase was founded in 1997 in Irvine, United States, focusing on femtosecond laser technology within the medical sector, particularly for ophthalmology. The technology, now trademarked as IntraLase and owned by AMO, enables IntraLASIK procedures. The company went public in 2004 and was acquired by Advanced Medical Optics in 2007 for 808 million. Advanced Medical Optics was subsequently acquired by Abbott Laboratories in 2009.
IntraLase's top competitors include Clerio Vision and Lenticular Research Group.
IntraLase has 3 investors. Key investors include Abbott, Brentwood Associates, and InterWest.
Yes. IntraLase was acquired by Abbott in March 2007.